RA Capital Management - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
RA Capital Management ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2015$1,439,000
+4.0%
116,4000.0%0.14%
+5.8%
Q1 2015$1,383,000
+5.2%
116,4000.0%0.14%
-2.8%
Q4 2014$1,315,000
+28.7%
116,4000.0%0.14%
+16.5%
Q3 2014$1,022,000116,4000.12%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,100,140$25,968,0006.81%
Portolan Capital Management 664,298$8,214,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,122,0001.10%
Opus Point Partners Management, LLC 72,009$890,0000.70%
Eagle Ridge Investment Management 122,500$1,515,0000.68%
EAM Investors, LLC 350,410$4,333,0000.51%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,881,667$60,362,0000.37%
Cannell & Co. 1,051,178$12,998,0000.37%
Birchview Capital, LP 42,300$523,0000.28%
Tekla Capital Management LLC 567,787$7,021,0000.25%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders